最近話題の輸血後感染症ヒトパルボウイルスB19とその感染症について

Saved in:
Bibliographic Details
Published in日本輸血学会雑誌 Vol. 42; no. 3; pp. 74 - 82
Main Author 佐藤, 博行
Format Journal Article
LanguageJapanese
Published 一般社団法人 日本輸血・細胞治療学会 01.06.1996
Subjects
Online AccessGet full text
ISSN0546-1448
1883-8383
DOI10.3925/jjtc1958.42.74

Cover

Loading…
Author 佐藤, 博行
Author_xml – sequence: 1
  fullname: 佐藤, 博行
  organization: 福岡県赤十字血液センター
BookMark eNpFUE1LAkEAHcIgM6_9i7WZnQ9njiV9gdCljrHMzs6Wi1nseunmuEIevFiHLoYIIoUQdCuI-jFDtv2LCvu4vPfgfRzeMsg1ThsagFUES1i4dC2KmgoJykvELZXJAsgjzrHDMcc5kIeUMAcRwpdAMUlqPqQYC8hdlgeHs0Ere-1ndw8fo54199nzYzZqvb30Zp3hbHj1fn1h00ubdm3at-nUpgPbntj2-Fu3nzaQsObWmpuv4n_eTK0ZW9OxZrICFkNZT3TxhwvgYGtzv7LjVPe2dyvrVSdCgkBHEKV8hRniIUE4FIHULtWYU4UCEkItIWLUV1DhcgADqH3JJA-YG_iUCV8SXACV-W6UNOWR9s7i2omMzz0ZN2uqrr3fdzziengOZfLnqmMZe5HEn4i-gao
ContentType Journal Article
Copyright 日本輸血・細胞治療学会
Copyright_xml – notice: 日本輸血・細胞治療学会
DOI 10.3925/jjtc1958.42.74
DeliveryMethod fulltext_linktorsrc
EISSN 1883-8383
EndPage 82
ExternalDocumentID article_jjtc1958_42_3_42_3_74_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
JSF
KQ8
MOJWN
RJT
ID FETCH-LOGICAL-j1940-94ccbc3618f413f9dae25e385c1d4f0ea0165bc0c37d0d0eba6a8d62db569ba43
ISSN 0546-1448
IngestDate Wed Sep 03 06:29:58 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 3
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j1940-94ccbc3618f413f9dae25e385c1d4f0ea0165bc0c37d0d0eba6a8d62db569ba43
OpenAccessLink https://www.jstage.jst.go.jp/article/jjtc1958/42/3/42_3_74/_article/-char/ja
PageCount 9
ParticipantIDs jstage_primary_article_jjtc1958_42_3_42_3_74_article_char_ja
PublicationCentury 1900
PublicationDate 1996/06/01
PublicationDateYYYYMMDD 1996-06-01
PublicationDate_xml – month: 06
  year: 1996
  text: 1996/06/01
  day: 01
PublicationDecade 1990
PublicationTitle 日本輸血学会雑誌
PublicationTitleAlternate 日輸血会誌
PublicationYear 1996
Publisher 一般社団法人 日本輸血・細胞治療学会
Publisher_xml – name: 一般社団法人 日本輸血・細胞治療学会
References 2) Cossart, Y. E., Cant, B., Field, A. M., et al.: Parvovirus-like particles in human serum. Lancet, i: 72-73, 1975.
6) Brown, K. E., Anderson, S. M. and Young, N. S.: Erythrocyte P antigen: Cellular receptor for B19 parvovirus. Science, 262: 114-117, 1993.
14) Mortimer, P. P., Luban, N. L. C., Kelleher, J. F., et al.: Transmission of parvovirus-like virus by clotting-factor concentrates. Lancet, ii: 482-484, 1983.
19) McOmish, F., Yap, P. L., Jordan, A., et al.: Detection of parvovirus B19 in donated blood; a model system for screening by polymerase chain reaction. J. Clin. Microbiol., 31: 323-328, 1993.
10) Brown, T., Anand, A., Ritchie, L. D., et al.: Intrauterine parvovirus infection associated with hydrops fetalis. Lancet, ii: 1033-1034, 1984.
18) Sato, H., Takakura, F., Kojima, E., et al.: Screening of blood donors for human parvovirus B19. Lancet, 346: 1237-1238, 1995.
20) Bansal, G. P., Hatfield, J. A., Dunn, F. E., et al.: Candidate recombinant vaccine for human B19 parvovirus. J. Infect. Dis., 167: 1034-1044, 1993.
11) Brown, K. E., Spencer, W. G., Mayolo, J. A., et al.: Congenital anaemia after tansplacental B19 parvovirus infection. Lancet, 343: 895-896, 1994.
13) Adler, S. P., Manganello, A. M. A., Koch, W. C., et al.: Risk of human parvovirus B19 infections among school and hospital employees during endemic periods. J. Infect. Dis., 168: 361-368, 1993.
16) Brown, K. E., Hibbs, J. R., Gallinella, G., et al.: Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N. Engl. J. Med., 330: 1192-1196, 1994.
4) Pattison, J. R., Jones, S. E., Hodgson, J., et al.: Parvovirus infection and hypoplastic crisis in sickle-cell anemia. Lancet, i: 664-665, 1981.
12) Tsujimura, M., Matsushita, K., Shiraki, H., et al.: Human parvovirus B19 infection in blood donors. Vox Sang., 69: 206-212, 1995.
3) Okochi, K., Mori, R., Miyazaki, M. B., et al.: Nakatani, antigen and human parvovirus (B19). Lancet, i: 160-161, 1984.
15) Erdman, D. D., Usher, M. J., Tsou, C., et al.: Human parvovirus B19 specific IgG, IgA and IgM antibodies and DNA in serum specimens from persons with Erythema Infectiosum. J. Med. Virol., 35: 110-115, 1991.
9) Zanella, A., Rossi, F., Cesana, C., et al.: Transfusion-transmitted human parvovirus B19 infection in a Thalassemic patient. Transfusion, 35: 769-772, 1995.
17) Sato, H., Hirata, J., Kuroda, K., et al.: Identification and Mapping of Neutralizing Epitopes of Human Parvovirus B19 by Human Antibodies. J. Virol., 65: 5485-5490, 1991.
7) Anderson, M. J., Higgins, P. G., Davis, L. R., et al.: Experimental parvoviral infection in humans. J. Infectious Dis., 152: 257-265, 1985.
5) Ozawa, K., Ayub, J., Yu-shu, H., et al.: Novel transcription map for the B19 (human) pathogenic parvovirus. J. Viol., 61: 2395-2406, 1987.
8) Kurtzman, G., Frickhofen, N., Kimball, J., et al.: Pure red-cell aplasia of 10 years duration due tol persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N. Engl. J. Med., 321: 519-523, 1989.
1) Couroucé, A. M., Ferchal, F., Morinet, F., et al.: Parvovirus (SPLV) et antigène Aurillac, Revue Française de Transfusion et Immunohématologie, XXVII: 5-19, 1984.
21) Fairley, C. K., Smoleniec, J. S., Caul, O. E., et al.: Observational study of effect of intrauterine transfusion on outcome of fetal hydrops after parvovirus B19 infection. Lancet, 346: 1335-1337, 1995.
References_xml – reference: 7) Anderson, M. J., Higgins, P. G., Davis, L. R., et al.: Experimental parvoviral infection in humans. J. Infectious Dis., 152: 257-265, 1985.
– reference: 21) Fairley, C. K., Smoleniec, J. S., Caul, O. E., et al.: Observational study of effect of intrauterine transfusion on outcome of fetal hydrops after parvovirus B19 infection. Lancet, 346: 1335-1337, 1995.
– reference: 6) Brown, K. E., Anderson, S. M. and Young, N. S.: Erythrocyte P antigen: Cellular receptor for B19 parvovirus. Science, 262: 114-117, 1993.
– reference: 2) Cossart, Y. E., Cant, B., Field, A. M., et al.: Parvovirus-like particles in human serum. Lancet, i: 72-73, 1975.
– reference: 4) Pattison, J. R., Jones, S. E., Hodgson, J., et al.: Parvovirus infection and hypoplastic crisis in sickle-cell anemia. Lancet, i: 664-665, 1981.
– reference: 10) Brown, T., Anand, A., Ritchie, L. D., et al.: Intrauterine parvovirus infection associated with hydrops fetalis. Lancet, ii: 1033-1034, 1984.
– reference: 17) Sato, H., Hirata, J., Kuroda, K., et al.: Identification and Mapping of Neutralizing Epitopes of Human Parvovirus B19 by Human Antibodies. J. Virol., 65: 5485-5490, 1991.
– reference: 16) Brown, K. E., Hibbs, J. R., Gallinella, G., et al.: Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N. Engl. J. Med., 330: 1192-1196, 1994.
– reference: 19) McOmish, F., Yap, P. L., Jordan, A., et al.: Detection of parvovirus B19 in donated blood; a model system for screening by polymerase chain reaction. J. Clin. Microbiol., 31: 323-328, 1993.
– reference: 1) Couroucé, A. M., Ferchal, F., Morinet, F., et al.: Parvovirus (SPLV) et antigène Aurillac, Revue Française de Transfusion et Immunohématologie, XXVII: 5-19, 1984.
– reference: 15) Erdman, D. D., Usher, M. J., Tsou, C., et al.: Human parvovirus B19 specific IgG, IgA and IgM antibodies and DNA in serum specimens from persons with Erythema Infectiosum. J. Med. Virol., 35: 110-115, 1991.
– reference: 18) Sato, H., Takakura, F., Kojima, E., et al.: Screening of blood donors for human parvovirus B19. Lancet, 346: 1237-1238, 1995.
– reference: 12) Tsujimura, M., Matsushita, K., Shiraki, H., et al.: Human parvovirus B19 infection in blood donors. Vox Sang., 69: 206-212, 1995.
– reference: 20) Bansal, G. P., Hatfield, J. A., Dunn, F. E., et al.: Candidate recombinant vaccine for human B19 parvovirus. J. Infect. Dis., 167: 1034-1044, 1993.
– reference: 11) Brown, K. E., Spencer, W. G., Mayolo, J. A., et al.: Congenital anaemia after tansplacental B19 parvovirus infection. Lancet, 343: 895-896, 1994.
– reference: 5) Ozawa, K., Ayub, J., Yu-shu, H., et al.: Novel transcription map for the B19 (human) pathogenic parvovirus. J. Viol., 61: 2395-2406, 1987.
– reference: 9) Zanella, A., Rossi, F., Cesana, C., et al.: Transfusion-transmitted human parvovirus B19 infection in a Thalassemic patient. Transfusion, 35: 769-772, 1995.
– reference: 14) Mortimer, P. P., Luban, N. L. C., Kelleher, J. F., et al.: Transmission of parvovirus-like virus by clotting-factor concentrates. Lancet, ii: 482-484, 1983.
– reference: 3) Okochi, K., Mori, R., Miyazaki, M. B., et al.: Nakatani, antigen and human parvovirus (B19). Lancet, i: 160-161, 1984.
– reference: 8) Kurtzman, G., Frickhofen, N., Kimball, J., et al.: Pure red-cell aplasia of 10 years duration due tol persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N. Engl. J. Med., 321: 519-523, 1989.
– reference: 13) Adler, S. P., Manganello, A. M. A., Koch, W. C., et al.: Risk of human parvovirus B19 infections among school and hospital employees during endemic periods. J. Infect. Dis., 168: 361-368, 1993.
SSID ssib053390826
ssj0001818654
ssib005879765
ssib000872077
ssib058493955
Score 1.4315301
SourceID jstage
SourceType Publisher
StartPage 74
SubjectTerms ヒトパルボウイルスB19血球凝集反応
感染症
血漿分画製剤
輸血
Title 最近話題の輸血後感染症ヒトパルボウイルスB19とその感染症について
URI https://www.jstage.jst.go.jp/article/jjtc1958/42/3/42_3_74/_article/-char/ja
Volume 42
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 日本輸血学会雑誌, 1996/06/01, Vol.42(3), pp.74-82
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Na9VAEA-1XryIouI3PbgnyTOb3WR3wcvue3kURUFooRcJ-XqHd6girxdPTV9BD71UD14qpVCKUhC8KYj-KR6C9flfOLvJtikWaRVCGDYzv-zObJiZsLPrOLcgZs0FC5ibDXDg0tTjLg8YhZwHs5SxQegluhr5wcNwdp7eWwgWpk59b61aWhqlnez5kXUl_2JVaAO76irZE1h2HxQagAb7wh0sDPdj2RhFIRJdvVgh4kj1kcCakAIpIASSGPEuighEi0hGhqeLFDc82EgFSEWGJ0ScItE3gIBDUMSQYIgzI06Q8BuCc9uCG0Iq21K_y0cytAQ9zOMjJRQWtku8IUSv1cm_9wRbKGzBseZvWsJ2qG0QGJJBoyXZPVoDsmc6TPUjIbXehLKalKAcOyUNSw8Jo2wNTPX01Ai8ZwRrzO7Bf5R66XXY_o9iQHhjMdCl7pSBAjsAErxZEt1fBeoMDLOE6_bxxmJUrZRGVCBZvwOAjFaV3zwSQhvij4G3PEJAQxcy4NphFbXH4py4nNSnAVmXRv3Wp0ta_qk-EclGOv5RPhQCZr3dyHA4yvRGRB3qd6zUoX3Jm1kfW8aY-jGpb4zG9qmuHYyHkMCc9hkz6yjuP2rH_8z32oXQnEF4vO9gIBURXiv_hWBZENEUUpufqHo_RnPS4b5q6o1Z9SDuHB4ChJhDSLjsYk0TP86dc842id-MrHt83pkaJhecx3sby5Nv65P3H39trVXlh8mXT5Ot5R9f1_ZWN_c2X_9886Iav6rGL6vxejXercYb1cpOtbKt6ZXP8CVV5buqfAuCB_zlblVuV-VqVe5cdOb70Vx31m0OPHGHWFDPFTTL0oyEmA8gthyIPCn8oCA8yHBOB16R6NrDNPMywnIv94o0CROeh36eBqFIE0ouOdOLTxaLy85Mkmc-KAsAc4-KQqSDIktxmORJigtRZFecu7U24qf1rjbxiex59f_ErzlnDj7B68706NlScQOC-1F600yQ36j6zSE
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E6%9C%80%E8%BF%91%E8%A9%B1%E9%A1%8C%E3%81%AE%E8%BC%B8%E8%A1%80%E5%BE%8C%E6%84%9F%E6%9F%93%E7%97%87%E3%83%92%E3%83%88%E3%83%91%E3%83%AB%E3%83%9C%E3%82%A6%E3%82%A4%E3%83%AB%E3%82%B9B19%E3%81%A8%E3%81%9D%E3%81%AE%E6%84%9F%E6%9F%93%E7%97%87%E3%81%AB%E3%81%A4%E3%81%84%E3%81%A6&rft.jtitle=%E6%97%A5%E6%9C%AC%E8%BC%B8%E8%A1%80%E5%AD%A6%E4%BC%9A%E9%9B%91%E8%AA%8C&rft.au=%E4%BD%90%E8%97%A4%2C+%E5%8D%9A%E8%A1%8C&rft.date=1996-06-01&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E8%BC%B8%E8%A1%80%E3%83%BB%E7%B4%B0%E8%83%9E%E6%B2%BB%E7%99%82%E5%AD%A6%E4%BC%9A&rft.issn=0546-1448&rft.eissn=1883-8383&rft.volume=42&rft.issue=3&rft.spage=74&rft.epage=82&rft_id=info:doi/10.3925%2Fjjtc1958.42.74&rft.externalDocID=article_jjtc1958_42_3_42_3_74_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0546-1448&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0546-1448&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0546-1448&client=summon